申请人:ZARODEX THERAPEUTICS LTD
公开号:WO2019149861A1
公开(公告)日:2019-08-08
This invention relates to the compound clozapine and its major metabolite norclozapine and prodrugs thereof and pharmaceutically acceptable salts and solvates thereof for use in the treatment or prevention of a pathogenic immunoglobulin driven B cell disease. The invention also provides pharmaceutical compositions containing such compounds.